We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRC
151
DELISTED
First Republic Bank
FRC
$10.3M 0.16%
111,513
+28,410
+34% +$2.32M
SHOP icon
152
Shopify
SHOP
$148B
$10.2M 0.16%
+2,383,460
New +$10M
HIMX
153
Himax Technologies
HIMX
$2.2B
$10.1M 0.16%
1,670,977
+514,926
+45% +$3.89M
IONS icon
154
Ionis Pharmaceuticals
IONS
$9.35B
$10M 0.16%
+210,000
New +$8.31M
PNC icon
155
PNC Financial Services
PNC
$100B
$9.51M 0.15%
81,300
+21,500
+36% +$2.24M
ARCC icon
156
Ares Capital
ARCC
$13.5B
$9.24M 0.15%
560,000
+35,000
+7% +$551K
BRO icon
157
Brown & Brown
BRO
$22.9B
$9.05M 0.14%
403,500
-366,500
-48% -$7.45M
BMY icon
158
Bristol-Myers Squibb
BMY
$127B
$8.77M 0.14%
150,000
+50,000
+50% +$2.73M
SLRC icon
159
SLR Investment Corp
SLRC
$706M
$8.57M 0.14%
412,000
+4,500
+1% +$92K
OSPN icon
160
OneSpan
OSPN
$562M
$8.08M 0.13%
592,870
-179,121
-23% -$2.69M
ABBV icon
161
AbbVie
ABBV
$458B
$7.51M 0.12%
120,000
ULTI
162
DELISTED
Ultimate Software Group Inc
ULTI
$7.11M 0.11%
38,973
+5,007
+15% +$1M
KLAC icon
163
KLA
KLAC
$275B
$6.92M 0.11%
+879,350
New +$6.72M
PFLT icon
164
PennantPark Floating Rate Capital
PFLT
$681M
$6.87M 0.11%
487,500
+15,000
+3% +$203K
PAYC icon
165
Paycom
PAYC
$6.78B
$6.59M 0.11%
144,963
-191,326
-57% -$8.89M
HCA icon
166
HCA Healthcare
HCA
$84.8B
$6.59M 0.11%
89,000
+69,000
+345% +$5.17M
QCOM icon
167
Qualcomm
QCOM
$176B
$6.52M 0.1%
100,024
+24
+0% +$1.61K
BIIB icon
168
Biogen
BIIB
$29.9B
$6.52M 0.1%
23,000
+7,750
+51% +$2.3M
MBT
169
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$6.38M 0.1%
+700,000
New +$5.63M
BX icon
170
Blackstone
BX
$104B
$6.37M 0.1%
235,817
+8,234
+4% +$214K
AVGO icon
171
Broadcom
AVGO
$1.82T
$6.36M 0.1%
359,870
-301,000
-46% -$5.21M
USB icon
172
US Bancorp
USB
$99.6B
$6.27M 0.1%
122,101
+4,092
+3% +$195K
BKNG icon
173
Booking.com
BKNG
$138B
$6.2M 0.1%
105,750
+22,275
+27% +$1.33M
EBAY icon
174
eBay
EBAY
$48.6B
$5.75M 0.09%
193,781
-78,230
-29% -$2.31M
SIVB
175
DELISTED
SVB Financial Group
SIVB
$5.72M 0.09%
33,345
-5,100
-13% -$731K

Similar funds

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.